Association between systemic sclerosis, palmar fasciitis with polyarthritis, Raynaud's phenomenon and erythromelalgia with underlying malignancy

The symptoms of a rheumatic disease may also be a sign of a proliferative process. These include conditions that present with skin and vascular changes such as systemic sclerosis and Raynaud's phenomenon with peripheral ischaemia and ulceration. Furthermore, the less common conditions - erythro...

Full description

Saved in:
Bibliographic Details
Published inReumatologia Vol. 60; no. 4; pp. 275 - 280
Main Authors Nowak, Katarzyna, Wright, Gary
Format Journal Article
LanguageEnglish
Published Poland Termedia Publishing House 2022
Subjects
Abdomen
Anorectal
anti-rna polymerase iii antibody
Antibodies
Autoimmune diseases
Chemotherapy
Connective tissue diseases
Edema
erythromelalgia
Fasciitis
Fecal incontinence
Hematology
Immunology
Ischemia
Kidney cancer
Literature reviews
Lung cancer
Malignancy
Medical imaging
Metastasis
Ovarian cancer
palmar fibromatosis
paraneoplastic syndrome
Patients
Polyarthritis
Prostate
raynaud’s syndrome
Renal cell carcinoma
Rheumatic diseases
Rheumatology
RNA polymerase
Scleroderma
Skin
Systemic sclerosis
Tumors
erythromelalgia
anti-RNA polymerase III antibody
systemic sclerosis
Raynaud’s syndrome
palmar fibromatosis
paraneoplastic syndrome
Online AccessGet full text

Cover

More Information
Summary:The symptoms of a rheumatic disease may also be a sign of a proliferative process. These include conditions that present with skin and vascular changes such as systemic sclerosis and Raynaud's phenomenon with peripheral ischaemia and ulceration. Furthermore, the less common conditions - erythromelalgia or palmar fasciitis with polyarthritis may also accompany cancer. In this article, we discuss the association of diffuse systemic sclerosis with anorectal tumor, palmar fasciitis and polyarthritis with ovarian cancer, erythromelalgia with underlying ovarian malignancy and Raynaud's phenomenon and digital ischemia associated with renal carcinoma. Based on the literature review on this topic we highlighted the importance of recognizing paraneoplastic syndromes at an early stage. This is a crucial point in the adequate management of a patient. Many of the paraneoplastic symptoms of rheumatic and other described conditions may regress with the management of the underlying malignancy.
ISSN:0034-6233
2084-9834
DOI:10.5114/reum.2022.119044